ARS Pharmaceuticals, Inc. (NASDAQ:SPRY) Events
Events
Calls
| Call | When | Status |
|---|---|---|
| ARS Pharmaceuticals (NASDAQ:SPRY) Q3 2026 Earnings Call | Thu, Nov 05, 2026 · 4:30 PM ET | Replay |
| ARS Pharmaceuticals (NASDAQ:SPRY) Q2 2026 Earnings Call | Thu, Aug 13, 2026 · 4:30 PM ET | Replay |
| ARS Pharmaceuticals (NASDAQ:SPRY) Q1 2026 Earnings Call | Fri, May 15, 2026 · 8:30 AM ET | Replay |
| ARS Pharmaceuticals (NASDAQ:SPRY) Q4 2025 Earnings Call | Mon, Mar 09, 2026 · 8:30 AM ET | Replay |
| ARS Pharmaceuticals (NASDAQ:SPRY) Q3 2025 Earnings Call | Mon, Nov 10, 2025 · 8:30 AM ET | Replay |
| ARS Pharmaceuticals (NASDAQ:SPRY) Q2 2025 Earnings Call | Wed, Aug 13, 2025 · 8:30 AM ET | Replay |
| ARS Pharmaceuticals (NASDAQ:SPRY) Q1 2025 Earnings Call | Wed, May 14, 2025 · 8:30 AM ET | Replay |
| ARS Pharmaceuticals (NASDAQ:SPRY) Q4 2024 Earnings Call | Thu, Mar 20, 2025 · 8:30 AM ET | Replay |
| ARS Pharmaceuticals (NASDAQ:SPRY) Q3 2024 Earnings Call | Wed, Nov 13, 2024 · 8:00 AM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · After close | +5.3% |
| Q2 2026 | Aug 13, 2026 · After close | −7.4% |
| Q1 2026 | May 15, 2026 · Before open | −6.5% |
| Q4 2025 | Mar 19, 2026 | −1.6% |
| Q3 2025 | Nov 10, 2025 · Before open | +0.3% |
| Q2 2025 | Aug 13, 2025 · Before open | −5.0% |
| Q1 2025 | May 14, 2025 · Before open | −9.4% |
| Q4 2024 | Mar 19, 2025 · Before open | +1.0% |
| Q3 2024 | Nov 13, 2024 · Before open | −15.2% |
| Q2 2024 | Aug 6, 2024 · After close | −2.2% |
| Q1 2024 | May 9, 2024 · After close | −0.7% |
| Q4 2023 | Mar 21, 2024 · After close | −3.9% |
| Q3 2023 | Nov 9, 2023 · After close | +8.8% |
| Q2 2023 | Aug 10, 2023 · After close | −0.3% |
| Q1 2023 | May 15, 2023 · Before open | −2.9% |
| Q4 2022 | Mar 23, 2023 · After close | −4.0% |
| Q3 2022 | Nov 2, 2022 · After close | −2.7% |
| Q2 2022 | Aug 11, 2022 · After close | −1.9% |
| Q1 2022 | May 12, 2022 · After close | −2.3% |
| Q4 2021 | Mar 31, 2022 · After close | −8.6% |